Journal
COLLOIDS AND SURFACES B-BIOINTERFACES
Volume 135, Issue -, Pages 291-308Publisher
ELSEVIER
DOI: 10.1016/j.colsurfb.2015.07.046
Keywords
Multi-drug delivery; Polymeric micelle; Synergistic effects; Sequential drug delivery; Cancer; Solubilization; Targeting; Nutraceuticals; siRNA
Funding
- Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, Govt. of India
Ask authors/readers for more resources
Multi-drug therapy is described as a simultaneous or sequential administration of two or more drugs with similar or different mechanisms of action and is recognized as a more efficient solution to combat successfully, various ailments. Polymeric micelles (PMs) are self-assemblies of block copolymers providing numerous opportunities for drug delivery. To date various micellar formulations were studied for delivery of drugs, nutraceuticals and genes; a few of them are in clinical trials. It was observed that there is an immense need for the development of PMs embedding multiple therapeutic agents to combat various ailments, including cancers, HIV/AIDS, malaria, multiple sclerosis, hypertension, infectious diseases, cardiovascular and metabolic diseases, immune disorders and many psychiatric disorders. Several combinations of drug-drug, drug-nutraceutical, drug-gene and drug-siRNA explored to date are detailed in this review, with a special emphasis on their potential and future perspectives. A summary of various preparation methods, characterization techniques and applications of PMs are also provided. This review presents a holistic approach on multi-drug delivery using micellar carriers and emphasizes on the development of therapeutic hybrids embedding novel combinations for safer and effective therapy. (C) 2015 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available